Publications in collaboration with researchers from Hospital de Sant Pau i Santa Tecla (32)

2020

  1. Recommendations of the Working Groups from the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) for the management of adult critically ill patients in the coronavirus disease (COVID-19)

    Medicina Intensiva, Vol. 44, Núm. 6, pp. 371-388

2018

  1. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study

    Contact Dermatitis, Vol. 78, Núm. 1, pp. 76-82

2017

  1. Contact sensitization to limonene and linalool hydroperoxides in Spain: a GEIDAC* prospective study

    Contact Dermatitis, Vol. 76, Núm. 2, pp. 74-80

  2. Prognostic accuracy of SIRS criteria, qSOFA score and GYM score for 30-day-mortality in older non-severely dependent infected patients attended in the emergency department

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 36, Núm. 12, pp. 2361-2369

2016

  1. An assessment of the management of spasticity in Spain: The 5E study

    Revista de Neurologia, Vol. 63, Núm. 7, pp. 289-296

  2. Infection-related and -unrelated malignancies, HIV and the aging population

    HIV Medicine, Vol. 17, Núm. 8, pp. 590-600

  3. Long-term adherence to continuous positive airway pressure therapy in non-sleepy sleep apnea patients

    Sleep Medicine, Vol. 17, pp. 1-6

2015

  1. Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study

    HIV Medicine, Vol. 16, Núm. 9, pp. 533-543

  2. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3

2014

  1. A survey of ATRIPLA use in clinical practice as first-line therapy in HIV-positive persons in Europe

    Infection, Vol. 42, Núm. 4, pp. 757-762

  2. Immuno-virological discordance and the risk of non-AIDS and AIDS events in a large observational cohort of HIV-patients in Europe

    PLoS ONE, Vol. 9, Núm. 1

2013

  1. Does smoking influence Crohn's disease in the biologic era? the TABACROHN study

    Inflammatory Bowel Diseases, Vol. 19, Núm. 1, pp. 23-29

  2. High smoking cessation rate in Crohn's disease patients after physician advice - The TABACROHN Study

    Journal of Crohn's and Colitis, Vol. 7, Núm. 3, pp. 202-207

  3. Hyaluronic Acid Levels Predict Risk of Hepatic Encephalopathy and Liver-Related Death in HIV/Viral Hepatitis Coinfected Patients

    PLoS ONE, Vol. 8, Núm. 5

  4. Smoking does influence disease behaviour and impacts the need for therapy in Crohn′s disease in the biologic era

    Alimentary Pharmacology and Therapeutics, Vol. 38, Núm. 7, pp. 752-760

2012

  1. Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease

    Haematologica, Vol. 97, Núm. 4, pp. 616-621

  2. Comparison of high ribavirin induction versus standard ribavirin dosing, plus peginterferon-for the treatment of chronic hepatitis C in HIV-infected patients: The PERICO trial

    Journal of Infectious Diseases, Vol. 206, Núm. 6, pp. 961-968

  3. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea: A randomized controlled trial

    JAMA - Journal of the American Medical Association, Vol. 307, Núm. 20, pp. 2161-2168

  4. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): A multicentre, open-label, randomised phase 3 trial

    The Lancet Oncology, Vol. 13, Núm. 3, pp. 239-246

  5. Estudio transversal, descriptivo, multicéntrico de las creencias y actitudes de las mujeres españolas frente a las nuevas opciones médicas con estradiol natural en anticoncepción hormonal oral. estudio creación

    Revista Iberoamericana de Fertilidad y Reproduccion Humana, Vol. 29, Núm. 2